Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05826665 · ClinicalTrials.gov registry record
Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System
A clinical trial of Persistent Atrial Fibrillation, sponsored by Kansas City Heart Rhythm Research Foundation.
- Recruiting
- Registry status
- 200
- Enrollment target
- 4
- Study locations
NCT05826665: Recruiting study of Persistent Atrial Fibrillation, sponsored by Kansas City Heart Rhythm Research Foundation.
NCT05826665 is a study of Persistent Atrial Fibrillation that is actively recruiting participants, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 200 participants, below the 1,247-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (84% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05826665, a study of Persistent Atrial Fibrillation, is actively recruiting participants, sponsored by Kansas City Heart Rhythm Research Foundation.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 4
- Study locations
Study Summary
STAR Apollo Mapping System is an FDA cleared mapping technology that can analyze the signals collected during the ablation procedure on the 3D mapping system and give the physician further insight into the AF activation patterns which may assist them in identifying areas responsible for maintaining Atrial Fibrillation (AF). The STAR Apollo Mapping System system allows clinicians, after treating the Pulmonary Veins (PV), to collect data from the atria during clinical AF procedures using standard FDA cleared catheters and devices. This study aims to examine the impact of the STAR Apollo Mapping System on procedural and acute outcomes in a multicenter observational study.
Primary Outcome
The primary objective for the study is to determine the impact of STAR Apollo Mapping System on the procedural parameters of persistent AF ablation. These include procedure duration and the number of radiofrequency (RF) lesions applied post PVI.
Conditions Studied
Interventions
- OTHER Persistent AF ablation assisted with the STAR Apollo Mapping System
Study Locations (4)
Kansas
- Kansas City Heart Rhythm Institute - Roe Clinic - Overland Park
- Overland Park Regional Medical Center - Overland Park
Arkansas
- St.Bernards Medical Center - Jonesboro
Florida
- Sarasota Medical Center - Sarasota
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-10-02 |
| Est. Completion | 2025-07-31 |
What NCT05826665 shows while recruiting
NCT05826665 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,247-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Persistent Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Persistent AF ablation assisted with the STAR Apollo Mapping System is the first listed.
NCT05826665 reports a single indexed study location in Kansas, Arkansas, Florida.
Frequently Asked Questions
What is clinical trial NCT05826665 about?
NCT05826665 is a clinical study titled "Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System". STAR Apollo Mapping System is an FDA cleared mapping technology that can analyze the signals collected during the ablation procedure on the 3D mapping system and give the physician further insight into the AF activation patterns which may assist them in identifying areas responsible for maintaining ...
What is the current status of trial NCT05826665?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-10-02. Estimated completion is 2025-07-31.
What conditions does trial NCT05826665 study?
This clinical trial studies the following conditions: Persistent Atrial Fibrillation.
What interventions are being tested in trial NCT05826665?
The interventions under investigation include: Persistent AF ablation assisted with the STAR Apollo Mapping System (OTHER).
Who is sponsoring clinical trial NCT05826665?
This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05826665 being conducted?
This trial has 4 study locations across Arkansas, Florida, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Persistent Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05826665's enrollment target sits among peer trials
200 10th of 15 higher than 5 of 15 other Persistent Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Persistent Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endocardial Mapping With the CoreMap EP Mapping System
RECRUITING · NA
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
ARIADNE Clinical Trial
RECRUITING · NA
-
SPHERE Per-AF Post-Approval Study
RECRUITING
-
Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias
RECRUITING · Phase 4
-
Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI